Tackling TB: Expand access to and improve affordability of diagnostics and treatment

Statement by the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam.

Read More →

Janssen: Response to TB CAB letter

Janssen's response to TB CAB letter regarding pharmacokinetic studies, paediatric studies, and compassionate use of bedaquiline.

Read More →

World Health Organization sets out route map for scale up of treatment as prevention

WHO is working with countries to identify opportunities for expansion of treatment in line with its 2010 guidelines, which recommended treatment for all people living with HIV with CD4 cell counts below 350, all infants below the age of 2, and for everyone with TB and HIV or hepatitis B and HIV coinfection.

Read More →

Russia: Fight against TB plagued by shortfalls

Russia currently ranks third by the number of multidrug-resistant TB cases worldwide after China and India, countries with vastly larger populations.

Read More →

Novel agent works against resistant TB

The investigational drug delamanid may help combat multidrug-resistant tuberculosis, results of a phase II trial indicate.

Read More →

South Africa: Changes to ART guidelines

All HIV-positive TB patients, with immediate effect, are initiated on ART, irrespective of CD4 count.

Read More →

TB CAB: Open letters to drug companies and FDA on delanamid and bedaquiline

Open letters to Otsuka, Janssen Pharmaceutical Companies of Johnson & Johnson, Food and Drug Administration and European Medicines Agency.

Read More →

MSF: Opportunity to transform medical innovation before health ministers

Medical innovation is not delivering for the needs of people in developing countries. 65th World Health Assembly to debate binding convention on R&D.

Read More →

Scaling up interventions to achieve global tuberculosis control: progress and new developments

Tuberculosis is still one of the most important causes of death worldwide. Perseverance and renewed commitment are needed to achieve global control of tuberculosis, and ultimately, its elimination.

Read More →

Report: GeneXpert TB diagnostics take off in low-resource countries

As of the end of the first quarter of 2012, nearly 864,000 GeneXpert MTB/RIF rapid tuberculosis (TB) diagnostic cartridges had been procured under manufacturer Cephied’s concessional pricing mechanism.

Read More →

Page 78 of 86 · Total posts: 10

←First 77 78 79 Last→